MODERATOR
:
SPEAKER
(S):
Alexis Harvey, MSPH, Health Scientist, Centers for Disease Control and Prevention
Barbee Whitaker, PhD, Director, Research and AABB Center for Patient Safety, AABB
Patient qand Donor Safety Center Q&A
Mark Fung, MD, PhD, Medical Director, Blood Bank and Transfusion Services, Fletcher Allen Health Care/ Univ. of Vermont
Kevin Land, MD, VP of Clinical Services, Blood Systems, Inc.
Dr. Cassandra Josephson, MD, Professor, Emory University School of Medicine, Children's Healthcare of Atlanta
Description
This event provides an opportunity for a panel representing various public and private perspectives to discuss the current landscape in biovigilance. Included will be representatives from the CDC's National Healthcare Safety Network - Hemovigilance Module, AABB's Biovigilance Working Group who developed the definitions and content of the Hemovigilance Module, AABB's Donor Hemovigilance Working Group, and AABB's Patient and Donor Safety Center. Questions for the discussion are submitted before the scheduled session via the AABB website, at kiosks in the Cyber Connection located in the Boston Convention & Exhibition Center and during the session.
LEARNER OUTCOMES:
-
Describe services provided by AABB's Patient and Donor Safety Center and the confidentiality provisions the center affords.
-
Describe the rationale behind the development of the hemovigilance forms and definitions used in the Hemovigilance Module.
-
Explain and describe the CDC's Hemovigilance protocol and how to use the Hemovigilance Module of the National Healthcare Safety Network (NHSN).
-
Review other proposed or existing biovigilance systems.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.